Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages
Abstract Oncolytic viruses (OVs) for cancer treatment are in a rapid stage of development, and the direct tumor lysis and activation of a comprehensive host immune response are irreplaceable advantages of cancer Kratom immunotherapy.However, excessive antiviral immune responses also restrict the spread of OVs in vivo and the infection of tumor cell